Back
Inhibrx Biosciences, Inc. Vs. Seres Therapeutics, Inc. Industry Stock Comparison
Sell
42
INBX
Inhibrx Biosciences, Inc.
Last Price:
$78.82
Seasonality Move:
-1.59%
Sell
15
MCRB
Seres Therapeutics, Inc.
Last Price:
$14.85
Seasonality Move:
-11.78%
Sell
42
Inhibrx Biosciences, Inc. (INBX)
is a Sell
Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?
-
The current Inhibrx Biosciences, Inc. [INBX] share price is $77.98. The Score for INBX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Seres Therapeutics, Inc. (MCRB)
is a Sell
Is Seres Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Seres Therapeutics, Inc. [MCRB] share price is $14.44. The Score for MCRB is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
MCRB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
INBX Stock Price Chart
What is Inhibrx Biosciences, Inc.'s stock price today?
-
The Inhibrx Biosciences, Inc. share price today is $77.98The current trend is moderately bearish and INBX is experiencing selling pressure, which indicates risk of future bearish movement.
MCRB Stock Price Chart
What is Seres Therapeutics, Inc.'s stock price today?
-
The Seres Therapeutics, Inc. share price today is $14.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 46.65 | Sell |
| Chaikin Money Flow: | -108837 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.18 - 87.12) | Sell |
| Bollinger Bands (100): | (26.78 - 78.74) | Buy |
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.8 | Sell |
| Relative Strength Index (14 RSI): | 40.09 | Sell |
| Chaikin Money Flow: | -33292 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.18 - 17.34) | Sell |
| Bollinger Bands (100): | (15.28 - 20) | Sell |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.86 | Sell |
| 20-day SMA: | 83.33 | Sell |
| 50-day SMA: | 76.57 | Buy |
| 200-day SMA: | 34.07 | Buy |
| 8-day EMA: | 80.64 | Sell |
| 20-day EMA: | 81.35 | Sell |
| 50-day EMA: | 73.36 | Buy |
| 200-day EMA: | 43.4 | Buy |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.9 | Sell |
| 20-day SMA: | 16.02 | Sell |
| 50-day SMA: | 16.86 | Sell |
| 200-day SMA: | 14.14 | Buy |
| 8-day EMA: | 15.03 | Sell |
| 20-day EMA: | 15.85 | Sell |
| 50-day EMA: | 16.69 | Sell |
| 200-day EMA: | 16.14 | Sell |
Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.
Seres Therapeutics, Inc. Earnings Growth & MCRB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, a decrease this year of $11.20 per share, and a decrease next year of $1.03 per share.
Inhibrx Biosciences, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Seres Therapeutics, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||